Shadi Zamani
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Shadi Zamani has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
- Hamid Reza Marateb
Biomedical Engineering Department, Engineering Faculty, University of Isfahan, Isfahan 81746-73441, Iran
2 shared publications - Amirhossein Koochekian
Child Growth and Development Research Center, Research Institute for Primordial Prevention of Non-Communicable Disease, Isfahan University of Medical Sciences, Isfahan 81746-73461, Iran
1 shared publication - Farzaneh Fazilati
Department of Biomedical Engineering, Faculty of Engineering, University of Isfahan, Isfahan 8174673441, Iran
1 shared publication - Fateme Biriaei
Department of Biomedical Engineering, Faculty of Engineering, University of Isfahan, Isfahan 8174673441, Iran
1 shared publication - Fateme Sadeghipour
Department of Biomedical Engineering, Faculty of Engineering, University of Isfahan, Isfahan 8174673441, Iran
1 shared publication - Mahsa Mansourian
Department of Medical Physics, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran
1 shared publication
Latest Publications
- Open Access
- 25 February 2026
- Published by MDPI AG in Diagnostics
- Vol. 16 (5) , 666
TRIAGE: Trustworthy Reporting and Assessment for Clinical Gain and Effectiveness of AI Models
Machine learning (ML), including deep learning, kernel-based classifiers, and ensemble methods, is increasingly used to support clinical diagnosis in medical imaging, biosignal interpretation, and electronic health record (EHR)-based decision support. Despite rapid progress, many diagnostic AI studies still rely on limited retrospective evaluation and single summary measures (e.g., accuracy or AUC), creating a gap between reported model performance and evidence required for safe clinical adoption. This review proposes TRIAGE, a clinically grounded evaluation framework designed to organize diagnostic AI testing as an evidence pipeline aligned with real clinical use cases (screening, triage, second reading, and confirmatory testing). We summarize core discrimination metrics derived from the confusion matrix (sensitivity, specificity, predictive values, likelihood ratios, diagnostic odds ratio, and F-scores) and highlight the importance of prevalence and spectrum effects for interpreting predictive value and clinical workload. We further review evaluation strategies for multi-class and multi-label diagnostic tasks using appropriate aggregation methods (micro, macro, and weighted averaging) and set-based measures such as Hamming loss, exact match ratio, and Jaccard/IoU. Because diagnostic deployment is threshold-dependent, we integrate representation curves (ROC, precision–recall, lift, and cumulative gain) with calibration assessment and clinical utility analysis, including calibration slope, Brier score, and decision-curve analysis. We also address robustness and fairness evaluation, leakage-resistant validation designs (patient-grouped splits, stratified and temporal validation, and external validation), computational constraints relevant to deployment (latency, throughput, and energy use), and statistically sound model comparison with multiplicity control. A structured TRIAGE checklist table summarizing the evaluation parameters described in this review is provided in the main text to support reproducible and clinically interpretable reporting.
- 25 February 2026
- Published by MDPI AG in Diagnostics
- Vol. 16 (5) , 666
Open AccessTRIAGE: Trustworthy Reporting and Assessment for Clinical Gain and Effectiveness of AI Models
Machine learning (ML), including deep learning, kernel-based classifiers, and ensemble methods, is increasingly used to support clinical diagnosis in medical imaging, biosignal interpretation, and electronic health record (EHR)-based decision support. Despite rapid progress, many diagnostic AI studies still rely on limited retrospective evaluation and single summary measures (e.g., accuracy or AUC), creating a gap between reported model performance and evidence required for safe clinical adoption. This review proposes TRIAGE, a clinically grounded evaluation framework designed to organize diagnostic AI testing as an evidence pipeline aligned with real clinical use cases (screening, triage, second reading, and confirmatory testing). We summarize core discrimination metrics derived from the confusion matrix (sensitivity, specificity, predictive values, likelihood ratios, diagnostic odds ratio, and F-scores) and highlight the importance of prevalence and spectrum effects for interpreting predictive value and clinical workload. We further review evaluation strategies for multi-class and multi-label diagnostic tasks using appropriate aggregation methods (micro, macro, and weighted averaging) and set-based measures such as Hamming loss, exact match ratio, and Jaccard/IoU. Because diagnostic deployment is threshold-dependent, we integrate representation curves (ROC, precision–recall, lift, and cumulative gain) with calibration assessment and clinical utility analysis, including calibration slope, Brier score, and decision-curve analysis. We also address robustness and fairness evaluation, leakage-resistant validation designs (patient-grouped splits, stratified and temporal validation, and external validation), computational constraints relevant to deployment (latency, throughput, and energy use), and statistically sound model comparison with multiplicity control. A structured TRIAGE checklist table summarizing the evaluation parameters described in this review is provided in the main text to support reproducible and clinically interpretable reporting.
- Open Access
- 13 September 2024
- Published by MDPI AG in Information
- Vol. 15 (9) , 564
Prevention of Cardiometabolic Syndrome in Children and Adolescents Using Machine Learning and Noninvasive Factors: The CASPIAN-V Study
Cardiometabolic syndrome (CMS) is a growing concern in children and adolescents, marked by obesity, hypertension, insulin resistance, and dyslipidemia. This study aimed to predict CMS using machine learning based on data from the CASPIAN-V study, which involved 14,226 participants aged 7–18 years, with a CMS prevalence of 82.9%. We applied the XGBoost algorithm to analyze key noninvasive variables, including self-rated health, sunlight exposure, screen time, consanguinity, healthy and unhealthy dietary habits, discretionary salt and sugar consumption, birthweight, and birth order, father and mother education, oral hygiene behavior, and family history of dyslipidemia, obesity, hypertension, and diabetes using five-fold cross-validation. The model achieved high sensitivity (94.7% ± 4.8) and specificity (78.8% ± 13.7), with an area under the ROC curve (AUC) of 0.867 ± 0.087, indicating strong predictive performance and significantly outperformed triponderal mass index (TMI) (adjusted paired t-test; p < 0.05). The most critical selected modifiable factors were sunlight exposure, screen time, consanguinity, healthy and unhealthy diet, dietary fat type, and discretionary salt consumption. This study emphasizes the clinical importance of early identification of at-risk individuals to implement timely interventions. It offers a promising tool for CMS risk screening. These findings support using predictive analytics in clinical settings to address the rising CMS epidemic in children and adolescents.
- 13 September 2024
- Published by MDPI AG in Information
- Vol. 15 (9) , 564
Open AccessPrevention of Cardiometabolic Syndrome in Children and Adolescents Using Machine Learning and Noninvasive Factors: The CASPIAN-V Study
Cardiometabolic syndrome (CMS) is a growing concern in children and adolescents, marked by obesity, hypertension, insulin resistance, and dyslipidemia. This study aimed to predict CMS using machine learning based on data from the CASPIAN-V study, which involved 14,226 participants aged 7–18 years, with a CMS prevalence of 82.9%. We applied the XGBoost algorithm to analyze key noninvasive variables, including self-rated health, sunlight exposure, screen time, consanguinity, healthy and unhealthy dietary habits, discretionary salt and sugar consumption, birthweight, and birth order, father and mother education, oral hygiene behavior, and family history of dyslipidemia, obesity, hypertension, and diabetes using five-fold cross-validation. The model achieved high sensitivity (94.7% ± 4.8) and specificity (78.8% ± 13.7), with an area under the ROC curve (AUC) of 0.867 ± 0.087, indicating strong predictive performance and significantly outperformed triponderal mass index (TMI) (adjusted paired t-test; p < 0.05). The most critical selected modifiable factors were sunlight exposure, screen time, consanguinity, healthy and unhealthy diet, dietary fat type, and discretionary salt consumption. This study emphasizes the clinical importance of early identification of at-risk individuals to implement timely interventions. It offers a promising tool for CMS risk screening. These findings support using predictive analytics in clinical settings to address the rising CMS epidemic in children and adolescents.